In lung cancer, abnormal circadian rhythm gene expression might accelerate the initiation and progression through multiple pathways, including the regulation of c-myc, metastatic factors, immune cells, and cell cycle proteins (45). This evidence concerns the gene MYC and lung carcinoma.